Parainfluenza [clinicaltrials_resource:bdae79461632f53ae9b1b111ba0ef360]
A Study to Assess the Safety of Live Intranasal Sendai Virus Vaccine in Children and Toddlers [clinicaltrials:NCT00186927]Safety of and Immune Response to Recombinant Live-Attenuated Parainfluenza Type 1 Virus Vaccine [clinicaltrials:NCT00641017]A Phase II, Randomized, Double-blind, Placebo-controlled Study to Examine the Effects of DAS181 in Immunocompromised Subjects With Lower Respiratory Tract Parainfluenza Infection on Supplemental Oxygen [clinicaltrials:NCT01644877]An Open Label Study to Examine the Effects of DAS181 Administered by Dry Powder Inhaler (DPI) or Nebulized Formulation in Immunocompromised Subjects With Parainfluenza (PIV) Infection [clinicaltrials:NCT01924793]
condition [clinicaltrials_vocabulary:condition]
Parainfluenza [clinicaltrials_resource:bdae79461632f53ae9b1b111ba0ef360]
Bio2RDF identifier
bdae79461632f53ae9b1b111ba0ef360
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:bdae79461632f53ae9b1b111ba0ef360
identifier
clinicaltrials_resource:bdae79461632f53ae9b1b111ba0ef360
title
Parainfluenza
@en
label
Parainfluenza [clinicaltrials_resource:bdae79461632f53ae9b1b111ba0ef360]
@en